On this week's podcast, Liam is joined by Aqil Ahsan, the founder and CEO of Kognitic, and Jaseem Mahmmdla, the co-founder and technologist behind their innovative AI-driven platform. Aqil has a background in mechanical engineering, having worked in automotive and aerospace industries, where he developed a passion for automation. Jaseem brings over 25 years of experience as a technologist with expertise in data analysis and product design, focusing on improving drug development processes. These passions led them to co-found Kognitic, applying automation and advanced technology to the clinical trial space.

In this episode, we explore how automation and AI are reshaping the pharmaceutical industry, delving into the challenges of data collection, patient recruitment, and trial efficiency. We discuss the importance of real-world evidence, efficacy benchmarking, and the critical role of natural language processing in accelerating drug development. The conversation also touches on the gap between pharma and other industries in adopting automation and the potential of AI to revolutionize clinical trials. Prepare for an insightful discussion on the future of drug development and how AI is transforming the industry and much more.

Ilya Gluhovsky and Paul Neyman join Liam on this week’s podcast episode. Ilya has an extensive background in software development, machine learning, and AI, with leadership roles in companies like Ancestry.com and Rally Health, and is now the co-founder of Areti Health, a company focused on revolutionizing patient recruitment in clinical trials using generative AI. Paul, with a background in computer science and sales, has successfully scaled multiple startups and now drives the sales strategy at Areti Health. In our discussion today, we dive into the challenges of patient recruitment in clinical trials, explore how generative AI is transforming the process, discuss the importance of personalized and culturally sensitive patient engagement, and uncover the future potential of AI in improving clinical trial efficiency and outcomes. We also touch on the misconceptions about AI in healthcare and a new standard for patient interaction and retention in clinical research, and much more.

Scott joins Liam on this week’s podcast episode. Scott has built an impressive career focused on patient recruitment and experience and DCT across several prominent companies, including Accenture, Verily, and also is a part of Decentralized Trials & Research Alliance (DTRA) as a Member Board of Directors. In our discussion today, we delve into a range of topics relating to recruitment and patient experience, we discuss what patient centricity means, explore how Scott would deliver clinical trials if he had a blank canvas, we explore what most people don’t know about patient recruitment and uncover what innovations Scott is most excited about and much more.